Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

Nanotechnology therapies can help improve quality of life for those with hair loss.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Two mouse mutations cause similar hair loss despite different skin changes.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Male pattern hair loss is diagnosed and treated earlier and is milder, possibly due to early puberty.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Women with PCOS often experience skin issues like excess hair, acne, and hair loss.

Finasteride lowers cortisol and raises testosterone levels in rats.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Testosterone pellets may help women's sexual function but have safety concerns and need more research.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.